{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:16:07Z","timestamp":1793697367150,"version":"4.5.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["2017003"],"award-info":[{"award-number":["2017003"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370383"],"award-info":[{"award-number":["82370383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515013289"],"award-info":[{"award-number":["2024A1515013289"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hrthm.2026.04.020","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:37:57Z","timestamp":1776443877000},"page":"e1947-e1957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Direct oral anticoagulants vs dual antiplatelet therapy following left atrial appendage closure in atrial fibrillation"],"prefix":"10.1016","volume":"23","author":[{"given":"Wulamiding","family":"Kaisaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-773X","authenticated-orcid":false,"given":"Yili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wengen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2026.04.020_bib1","article-title":"An international consensus practical guide on left atrial appendage closure for the non-implanting physician: executive summary","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2026.04.020_bib2","first-page":"2914","article-title":"Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives","volume":"45","author":"Landmesser","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.04.020_bib3","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: A meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib5","doi-asserted-by":"crossref","first-page":"e1048","DOI":"10.1016\/j.hrthm.2025.05.048","article-title":"SCAI\/HRS clinical practice guidelines on transcatheter left atrial appendage occlusion","volume":"22","author":"Goldsweig","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.020_bib6","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib7","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2026.04.020_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","article-title":"Reduced Rivaroxaban Dose versus Dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study","volume":"13","author":"Duthoit","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.125.077469","article-title":"Short-Term Anticoagulation versus Dual antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: the Andes Randomized Clinical Trial","author":"Rod\u00e9s-Cabau","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.020_bib12","unstructured":"Higgins JPT TJ. In: Chandler, J, Cumpston, M, Li, T, Page, MJ, Welch, VA, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; updated 2024:2024. Available from: www.cochrane.org\/handbook."},{"key":"10.1016\/j.hrthm.2026.04.020_bib13","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2026.04.020_bib14","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2026.04.020_bib15","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.hrthm.2025.06.023","article-title":"Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage","volume":"22","author":"Kaisaier","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.020_bib16","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1016\/j.hrthm.2025.07.051","article-title":"Left atrial appendage closure vs oral anticoagulation for stroke prevention in atrial fibrillation: long-term outcomes from 4 randomized trials","volume":"22","author":"Kaisaier","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.020_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2021.02.012","article-title":"A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies","volume":"135","author":"Xu","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2026.04.020_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10840-020-00884-x","article-title":"Rationale and design of a randomized clinical trial to compare two antithrombotic strategies after left atrial appendage occlusion: double antiplatelet therapy vs apixaban (ADALA study)","volume":"59","author":"Flores-Umanzor","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib20","article-title":"Different antithrombotic strategies after left atrial appendage closure with the LACbes occluder: protocol of the DAAL trial","volume":"15","author":"Zhang","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.hrthm.2026.04.020_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hrthm.2026.04.020_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(09)60738-8","article-title":"Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial","volume":"374","author":"Mega","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2026.04.020_bib23","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.020_bib24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.hrthm.2025.01.028","article-title":"Between Scylla and Charybdis: the unanswered conundrum of antithrombotic therapy after left atrial appendage closure","volume":"22","author":"Schmidt","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.020_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.020_bib26","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2026.04.020_bib27","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion","volume":"82","author":"Carvalho","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib28","first-page":"1311","article-title":"Comparative efficacy and safety of low-dose direct oral anticoagulants versus dual antiplatelet therapy following left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis","volume":"105","author":"Ibrahim","year":"2025","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.hrthm.2024.11.035","article-title":"Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis","volume":"22","author":"Lima","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2026.04.020_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ehjcvp\/pvaf078","article-title":"Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis","volume":"12","author":"Samaras","year":"2026","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.hrthm.2026.04.020_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.31083\/j.rcm2512450","article-title":"Comparative endothelialization of the Watchman plug device and LACBES pacifier occluder after left atrial appendage closure","volume":"25","author":"Zhou","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2026.04.020_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12872-024-04113-5","article-title":"Clinical incidence and relevance of incomplete endothelialization in atrial fibrillation patients with Left Atrial Appendage Closure","volume":"24","author":"Zhu","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hrthm.2026.04.020_bib33","first-page":"75","article-title":"Risk factors of incomplete endothelialization after left atrial appendage occlusion in patients with atrial fibrillation","volume":"21","author":"Chen","year":"2025","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.hrthm.2026.04.020_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101339","article-title":"Flow dynamic factors correlated with device-related thrombosis after left atrial appendage occlusion","volume":"3","author":"Vogl","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/acsabm.4c01005","article-title":"Enhanced endothelialization using resveratrol-loaded polylactic acid-coated left atrial appendage occluders in a canine model","volume":"8","author":"Hu","year":"2025","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.hrthm.2026.04.020_bib36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/ehjci\/jev067","article-title":"Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure","volume":"16","author":"Saw","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2026.04.020_bib37","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ehjci\/jey010","article-title":"Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study","volume":"19","author":"Cochet","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hrthm.2026.04.020_bib38","first-page":"306","article-title":"Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device","volume":"85","author":"Jaguszewski","year":"2015","journal-title":"Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib39","first-page":"384","volume":"146","author":"Jang","year":"2021"},{"key":"10.1016\/j.hrthm.2026.04.020_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib41","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion: an analysis of the amulet IDE trial","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib42","first-page":"1867","article-title":"Leak closure following left atrial appendage exclusion procedures: a multicenter registry","volume":"99","author":"Killu","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jcin.2022.12.006","article-title":"Peridevice leak after left atrial appendage occlusion: incidence, mechanisms, clinical impact, and management","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2026.04.020_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacep.2025.07.017","article-title":"Left atrial appendage occlusion in patients with prior intracranial hemorrhage","author":"Mansour","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2026.04.020_bib45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (amulet IDE): A randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2026.04.020_bib46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.acvd.2022.12.007","article-title":"Initiation and development of a percutaneous left atrial appendage closure programme: a French centre\u2018s experience and literature review","volume":"116","author":"Albert","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hrthm.2026.04.020_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030803","article-title":"Left atrial appendage occlusion and post-procedural antithrombotic management","volume":"13","author":"Kramer","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrthm.2026.04.020_bib48","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology guidelines for diagnosis and management of atrial fibrillation: A viewpoint from a practicing clinician\u2018s perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2026.04.020_bib49","article-title":"Patient Care Pathways and Risk Assessments in Patients with atrial fibrillation: A Comparison of Asian versus Non-Asian Cohorts","author":"Chang","year":"2025","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2026.04.020_bib50","article-title":"The \u2018Atrial Fibrillation Better Care\u2018 (ABC) pathway for integrated care of atrial fibrillation: A Systematic Review and Meta-Analysis","author":"Romiti","year":"2026","journal-title":"Thromb Haemost"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126022708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527126022708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:48:31Z","timestamp":1788378511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527126022708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1547527126022708"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.020","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct oral anticoagulants vs dual antiplatelet therapy following left atrial appendage closure in atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2026.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}